期刊文献+

MDR1基因单核苷酸多态性与肝细胞肝癌预后的关系 被引量:3

Correlation of MDR1 Single Nucleotide Polymorphism with Prognosis of Hepatocellular Carcinoma
原文传递
导出
摘要 [目的]探讨多药耐药基因1(multidrug resistance gene 1,MDR1)C1236T及C3435T单核苷酸多态性(SNP)与肝细胞肝癌(HCC)预后间关系。[方法]以36例HCC根治术患者为对象,同时建立50例对照组,PCR-SSCP法检测其静脉血标本C1236T及C3435T SNP,比较分析C1236T及C3435T SNP与HCC预后的关系。[结果]HCC组与对照组的基因分布无统计学差异(P>0.05)。C3435T基因型CC、CT、TT型中位无瘤生存时间依次为164.5d、340.0d和369.5d,C1236T基因型CC、CT、TT型中位无瘤生存时间依次为201.0d、415.0d、260.0d,MDR1基因多态性与HCC复发相关。[结论]C3435T SNP可作为肝癌根治术的预后因素之一。
出处 《肿瘤学杂志》 CAS 2011年第3期209-211,共3页 Journal of Chinese Oncology
基金 嘉兴市科技局基金项目(2008AY2034-5)
  • 相关文献

参考文献1

二级参考文献24

  • 1H uang GT,Lee HS,Chen CH,Sheu JC,Chiou LL,Chen DS.Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma. Hepato Gastroenterology . 1999
  • 2P haroah PD,Oliveira C,Machado JC,Keller G,Vogelsang H,Laux H,et al.CDH1 c-160a promoter polymorphism is not associated with risk of stomach cancer. International Journal of Cancer . 2002
  • 3L i LC,Chui RM,Sasaki M,Nakajima K,Perinchery G,Au HC,et al.A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Research . 2000
  • 4P ark WS,Cho YG,Park JY,Kim CJ,Lee JH,Kim HS,et al.A single nucleotide polymorphism in the E-cadherin gene promoter -160 is not associated with risk of Korean gastric cancer. Journal of Korean Medical Science . 2003
  • 5Y uan Y,Wang J,Li J,Wang L,Li M,Yang Z,et al.Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clinical Cancer Research . 2006
  • 6Z hang X,Ma X,Zhu QG,Li LC,Chen Z,Ye ZQ.Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder. Journal d Urologie . 2003
  • 7E ndo K,Ueda T,Ueyama J,Ohta T,Terada T.Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients’ survival. Human Pathology . 2000
  • 8Y ao FY,Bass NM,Ascher NL,Roberts JP.Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease(MELD) organ allocation policy. Liver Transplantation . 2004
  • 9T sujiuchi T,Shimizu K,Itsuzaki Y,Onishi M,Sugata E,Fujii H,et al.CpG site hypermethylation of E-cadherin and Connexin26 genes in hepatocellular carcinomas induced by a choline-deficient L-Amino Acid-defined diet in rats. Molecular Carcinogenesis . 2007
  • 10P orter TR,Richards FM,Houlston RS,Evans DG,Jankowski JA,Macdonald F,et al.Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncegene . 2002

共引文献5

同被引文献26

  • 1赵澎,胡微,张亚卓,孙梅珍,何乐.RNA干扰技术逆转神经胶质瘤细胞多药耐药性[J].中华肿瘤杂志,2006,28(3):183-187. 被引量:19
  • 2王宁,李玉,刘洁.肝癌患者多药耐药基因检测及其对介入治疗疗效影响分析[J].中国实验诊断学,2006,10(6):572-575. 被引量:5
  • 3赵建军,蔡建强,毕新宇,杨晓洁.槐耳颗粒对原发性肝癌术后转移复发的影响[J].中国综合临床,2007,23(3):245-247. 被引量:14
  • 4李立新,叶胜龙,王艳红,汤钊猷.槐耳浸膏的实验研究及临床应用进展[J].中国肿瘤,2007,16(2):110-113. 被引量:37
  • 5Germann UA,Pastan I,Gottesman MM. P-glycoproteins: mediators of multidrug resistance [jr]. Semin Cell Biol, 1993,4(1): 63-76.
  • 6Mayur YC,Jagadeesh S,Thimmaiah KN.Targeting calmodu- lin in reversing muhidrug resistance in cancer cells [J]. Mini Rev Med Chem,2006,6(12): 1383-1389.
  • 7Goda K, Fenyvesi F,Bacs6 Z,et al.Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody[J].JPharmacol Exp Ther, 2007,320(1) : 81-88.
  • 8Wu H, Hait WN,Yang JM.Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells[J].Cancer Res,2003,63 (7):1515-1519.
  • 9Nieth C,Priebsch A,Stege A,et al. Modulation of the classical multi-drug resistance (MDR) phenotype by RNA interference (RNAi) [J]. FEBS Lett,2003,545(2-3): 144- 150.
  • 10Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature, 2001,411(6836) :494-498.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部